Overview
Prospective registry and biobank for long-term observational studies in adult patients with pulmonary hypertension
Description
In a prospective registry prevalent and incident patients diagnosed with group 1 to 5 pulmonary hypertension will be enrolled. In an integrated biobank body fluid samples will be collected at enrollment and sequentially during treatment with targeted drugs for pulmonary hypertension.
Eligibility
Inclusion Criteria:
- Diagnosis of pulmonary hypertension group 1 to 5
- Ability to give informed consent
Exclusion Criteria:
- Withdrawal of informed consent